Page last updated: 2024-12-06

3-pentadecylphenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-pentadecylphenol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68146
CHEMBL ID34689
CHEBI ID174189
SCHEMBL ID135991
MeSH IDM0533265

Synonyms (51)

Synonym
LS-14918
CHEBI:174189
3-pentadecylphenol
phenol, 3-pentadecyl-
501-24-6
nsc9781
cyclogallipharaol
nsc-9781
anacardol, tetrahydro-
phenol, m-pentadecyl-
hydroginkgol
3-n-pentadecylphenol
m-pentadecylphenol
tetrahydroanacardol
hydrocardanol
3-pentadecylphenol, technical grade, 90%
bdbm50082305
CHEMBL34689 ,
5-pentadecylphenol
3-pentadecyl-phenol
3-pentadecyl phenol
inchi=1/c21h36o/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-20-17-15-18-21(22)19-20/h15,17-19,22h,2-14,16h2,1h3
ptfipecghsyqnr-uhfffaoysa-
einecs 207-921-9
nsc 9781
unii-j10atz45zu
j10atz45zu ,
A827983
AKOS015916272
SCHEMBL135991
phenol, 3-pentadecyl
2-deoxy-urushiol i
3-(n-pentadecyl)phenol
DTXSID9060108
W-105982
cardolite nc-507
cardolite nc-510
LMPK15010004
mfcd00002310
3-pentadecylphenol, analytical standard
phenol, m-pentadecyl- (8ci)
cardanol c15:0
cyclogallipharol
anacardol?
tetrahydro-anacardol
1-hydroxy-3-pentadecylbenzene
FT-0767049
Q27281005
D92087
CS-0185717
HY-W127489
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)IC50 (µMol)75.27005.66005.66005.6600AID401414; AID401415
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
in utero embryonic development1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
epidermal growth factor receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
phospholipid catabolic process1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
positive regulation of epithelial cell migration1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
cellular response to vascular endothelial growth factor stimulus1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
phosphatidylinositol metabolic process1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
cellular response to epidermal growth factor stimulus1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
phosphatidylinositol phospholipase C activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
guanyl-nucleotide exchange factor activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
calcium ion binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
protein binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
calcium-dependent phospholipase C activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
plasma membrane1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
ruffle1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
cytoplasm1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
lamellipodium1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
COP9 signalosome1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID401414Inhibition of bovine brain PI-PLCgamma1 at 125 ug/mL1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID401419Growth inhibition of human MCF7 cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID401421Growth inhibition of human SKOV3 cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID401420Growth inhibition of human HCT15 cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID68982Ability to inhibit autophosphorylation of NR11 and/or transphosphorylation of NR1 TCS proteins from E. coli; NT-Not tested1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems.
AID332455Inhibition of mushroom tyrosinase assessed as oxidation of L-DOPA at 0.8 mM1994Journal of natural products, Apr, Volume: 57, Issue:4
Tyrosinase inhibitors from Anacardium occidentale fruits.
AID40627Ability to inhibit autophosphorylation of KinA and/or Sp0F TCS proteins from Bacillus subtilis1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems.
AID401418Growth inhibition of human A549 cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID401423Growth inhibition of human CCD-18Co cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID1633668Permeability of the compound at pH 7.4 PBS buffer at 100 uM measured upto 6 hrs by PAMPA-BBB assay2019ACS medicinal chemistry letters, Apr-11, Volume: 10, Issue:4
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.
AID401422Growth inhibition of human HT1197 cells after 2 days by SRB assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
AID401415Inhibition of bovine brain PI-PLCgamma11998Journal of natural products, Jul, Volume: 61, Issue:7
Phospholipase Cgamma1 inhibitory principles from the sarcotestas of Ginkgo biloba.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.46 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index29.12 (26.88)
Search Engine Supply Index1.80 (0.95)

This Compound (31.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]